Drug Discovery News | Goodbye biopsies, non-invasive diagnostics for fatty liver disease are here
/in In the News /by davidMedsider Podcast | 4 Key Considerations to Win Over Investors: Interview with Glympse Bio CEO Caroline Loew
/in In the News /by davidThe LiverWELL Podcast | Dr. Tram Tran: Some good news about diagnosing NASH
/in In the News /by davidThe Medtech Podcast | Non-Invasive Biosensor Technology with Caroline J. Loew, Organic Chemistry, Disease Trajectories, Growing a Business Through a Pandemic and Advice for Startups
/in In the News /by Michael FrenchTechnology Networks | Effective Diagnostics for Liver Disease Are Urgently Needed (by Tram Tran, M.D.)
/in In the News /by davidScrip Intelligence | Scrip Asks…What Does 2022 Hold For Biopharma? Part 3: Technology And Science
/in In the News /by davidBioSpace | BioSpace Investigates Challenges with Compensation Disparity in the Life Sciences
/in In the News /by davidNPR Biotech Nation | Episode 22-03 Regeneron – how we create innovative scientists
/in In the News /by david35 Cambridgepark Drive
Suite 100
Cambridge, MA 02140
© 2022 Glympse Bio. All rights reserved.
Terms of Use | Privacy Policy | Other Policies
Design and development by RainCastle Communications.
Images by Liz Linder Photography.